Inhibitors of Nucleotide Biosynthesis as Candidates for a Wide Spectrum of Antiviral Chemotherapy

Emerging and re-emerging viruses have been a challenge in public health in recent decades. Host-targeted antivirals (HTA) directed at cellular molecules or pathways involved in virus multiplication represent an interesting strategy to combat viruses presently lacking effective chemotherapy. HTA could provide a wide range of agents with inhibitory activity against current and future viruses that share similar host requirements and reduce the possible selection of antiviral-resistant variants. Nucleotide metabolism is one of the more exploited host metabolic pathways as a potential antiviral target for several human viruses. This review focuses on the antiviral properties of the inhibitors of pyrimidine and purine nucleotide biosynthesis, with an emphasis on the rate-limiting enzymes dihydroorotate dehydrogenase (DHODH) and inosine monophosphate dehydrogenase (IMPDH) for which there are old and new drugs active against a broad spectrum of pathogenic viruses.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:10

Enthalten in:

Microorganisms - 10(2022), 8 vom: 12. Aug.

Sprache:

Englisch

Beteiligte Personen:

Sepúlveda, Claudia Soledad [VerfasserIn]
García, Cybele Carina [VerfasserIn]
Damonte, Elsa Beatriz [VerfasserIn]

Links:

Volltext

Themen:

DHODH inhibitors
De novo biosynthesis pathway
Host-targeted antiviral
IMPDH inhibitors
Journal Article
Nucleotide metabolism
Purines
Pyrimidines
Review
Salvage pathway
Wide-spectrum antiviral

Anmerkungen:

Date Revised 30.08.2022

published: Electronic

Citation Status PubMed-not-MEDLINE

doi:

10.3390/microorganisms10081631

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM345324439